SIM
NKTR icon

Spark Investment Management’s Nektar Therapeutics NKTR Stock Holding History

Spark Investment Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-913
Closed -$230K – 813
2015
Q4 		$230K Sell
913
-3,447
-79% -$709K 0.03% 557
2015
Q3 		$716K Buy
+4,360
New +$771K 0.09% 308
2015
Q1 		– Sell
-2,373
Closed -$551K – 742
2014
Q4 		$551K Buy
+2,373
New +$507K 0.09% 300

Other funds holding NKTR

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Spark Investment Management's NKTR Position: Q1 2016 in Review

Spark Investment Management sold out of Nektar Therapeutics (NKTR) in Q1 2016, closing a stake of 913 shares — an estimated $230K sold.

Spark Investment Management first reported a position in NKTR in Q4 2014 and held it in 3 quarters. The position peaked at $716K in Q3 2015. 176 funds tracked by Wall St. Rank hold NKTR as of Q1 2016.

  • Spark Investment Management reported no remaining Nektar Therapeutics position as of Q1 2016 after selling out during the quarter.
  • Spark Investment Management sold 913 Nektar Therapeutics shares in Q1 2016, an estimated $230K.
  • Spark Investment Management first reported a position in Nektar Therapeutics in Q4 2014 and held it in 3 quarters.
  • Spark Investment Management's Nektar Therapeutics position peaked at $716K in Q3 2015.
  • 176 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2016.

Based on Spark Investment Management's 13F filing for Q1 2016, filed 12 May 2016.